Izun Pharmaceuticals Corporation focuses on natural solutions in the area of periodontal inflammation.

Izuns products are both efficacious and safe, providing novel solutions with the potential to capitalize on multi-billion-dollar market opportunities.

Izun Pharma Ltd is a wholly-owned Jerusalem-based R&D subsidiary.

A proprietary, botanically-based platform technology was developed which helps treat a wide range of inflammatory diseases, while simultaneously accelerating the bodys natural tissue repair processes.